The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Sep 06, 2026
Snapshot (as of Sep 06, 2026): GSK plc (GSK) pays a $1.36 annual dividend ($0.34 quarterly), yielding 3.68% at $49.89/share. Next ex-dividend date 2026-08-14. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 3.68%
Annual Dividend: $1.36 per share
Payout Ratio: 55.3%
Ex-Dividend Date: 2026-08-14
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 43
GSK plc is a global pharmaceutical company with over three centuries of history, producing vaccines, HIV therapies, and treatments for respiratory conditions like asthma and COPD. The GSK plc dividend currently yields 3.68%, paid quarterly, with a trailing annual rate of $1.36 per share and the next ex-dividend date set for August 14, 2026. With a beta of 0.295, GSK stock moves far less than the broader market, which suits income-focused investors who prioritize low volatility over capital gains.
GSK plc pays out 55.3% of earnings as dividends, a payout ratio classified as moderate (40-60%). That level leaves a meaningful buffer of retained earnings, supported by a broad product portfolio spanning vaccines for shingles and RSV, specialty medicines for HIV and oncology, and inhaled treatments for chronic respiratory disease, all of which address ongoing medical demand. GSK plc dividend safety faces its most visible pressure from the long-term dividend per share trend: the annual payment has declined from $2.30 in 2008 to $1.71 in 2025, meaning the payout ratio alone does not tell the full story of income reliability.
GSK plc dividend history shows a CAGR of -1.7% per year from 2008 to 2025. Per-share payments fell from $2.2966 at the start of the window to $1.7055 by 2025 (with 2026 a partial year). The largest annual increase in the window was 10.3% in 2016, but the overall trend includes at least one year-over-year decline exceeding 5%, and growth is negative across the full period.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +0.2% | $1.70 (2022) | $1.71 (2025) |
| 5-Year | -4.7% | $2.17 (2020) | $1.71 (2025) |
| 10-Year | -3.4% | $2.41 (2015) | $1.71 (2025) |
GSK plc fits income-focused investors who want a moderate yield from a large, diversified pharmaceutical business and can accept a dividend that has declined in per-share terms over time. The current yield of 3.68% sits above the 5-year average of 3.43%, which is a positive signal for yield-seekers entering now. The payout ratio of 55.3% keeps the dividend within a moderate (2-4%) yield range without straining earnings. The trade-off is clear: GSK stock offers low market volatility and a meaningful quarterly income stream, but the dividend has not grown in real terms over the long run, and consecutive increases stand at just two years.
| Payment Date | Amount per Share |
|---|---|
| 2026-08-14 | $0.4515 |
| 2026-05-15 | $0.4550 |
| 2026-02-20 | $0.4776 |
| 2025-11-14 | $0.4331 |
| 2025-08-15 | $0.4300 |
| 2025-05-16 | $0.4348 |
| 2025-02-21 | $0.4076 |
| 2024-11-15 | $0.3769 |
| 2024-08-16 | $0.3928 |
| 2024-05-16 | $0.3843 |
| Year | Total Dividends |
|---|---|
| 2026 | $1.3841 |
| 2025 | $1.7055 |
| 2024 | $1.5589 |
| 2023 | $1.3938 |
| 2022 | $1.6974 |
Project income from GSK with the GSK dividend calculator or track your full portfolio with the dividend tracker.